Company: STAA
Filing Date: 2025-10-27
Form Type: PX14A6G
Source: 0001193125-25-250625
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-10-27
Form: PX14A6G
Chunk 2
---
 months, something that the Company has not
experienced in some time. However, if STAAR were to consummate a transaction under the existing Alcon framework, shareholders would not benefit from these positive market trends. We urge STAAR to report its current and historical in-market ICL sales volume from its distributors to their customers (i.e., eye surgery providers). This data will show the health of STAAR’s business in China from a demand perspective. That would put to rest
management speculations about less optimistic trends for ICL in China and let the data speak for itself. We think this data, which has been withheld from shareholders to date, would be a material factor for shareholders in making future voting
decisions.

We remain confident in STAAR’s long-term prospects and its ability to deliver strong revenue growth and profitability in 2026. We look
forward to working constructively with the Board and management team to realize the significant value that we believe STAAR can deliver.

Sincerely,

Christopher M. Wang

Founder and Chief Investment Officer

Yunqi Capital Limited

About Yunqi Capital

Yunqi Capital is a Hong Kong headquartered investment manager with over US$250 million in assets under management. The firm deploys a fundamental
long-short equity strategy, with a concentrated portfolio, that is primarily invested in the equity securities of companies with a significant China connection. Yunqi Capital is led by CIO Chris Wang, an experienced portfolio manager with a strong
track record of generating attractive returns on capital, controlling portfolio risk and managing investment teams.

Disclaimers

THIS IS NOT A SOLICITATION OF AUTHORITY TO VOTE YOUR PROXY. DO NOT SEND US YOUR PROXY CARD OR OTHER VOTING INSTRUCTION FORM. YUNQI CAPITAL IS NOT ASKING FOR
YOUR PROXY AND WILL NOT ACCEPT PROXY CARDS IF SENT. YUNQI CAPITAL IS NOT ABLE TO VOTE YOUR PROXY, NOR DOES THIS COMMUNICATION CONTEMPLATE SUCH AN EVENT.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in any state to any
person. This press release does not recommend the purchase or sale of a security. There is no assurance or guarantee with respect to the prices at which any securities of the Company will trade, and such securities may not trade at prices that may
be implied herein. In addition, this press release and the discussions and opinions herein are for general information only, and are not intended to